Showing results (251-260 of 327) with videos related to
Sort By:
Pageof 33
Proceedings of the National Academy of Sciences of the United States of America|December 24, 1996
Cytotoxic T lymphocytes and viral turnover in HIV type 1 infectionP Klenerman, R E Phillips, C R Rinaldo, et al.Archives of Internal Medicine|August 8, 1994
Evaluation of ondansetron prescribing in US academic medical centersL C Vermeulen, K A Matuszewski, T A Ratko, et al.Human Immunology|October 1, 1987
Functional and biochemical subtypes of the haplotype HLA-DR3 in patients with celiac disease or idiopathic membranous nephropathyS H Sacks, A Bushell, N A Rust, et al.AIDS (London, England)|September 1, 1990
An HIV-1 and HIV-2 cross-reactive cytotoxic T-cell epitopeD F Nixon, S Huet, J Rothbard, et al.The Journal of Experimental Medicine|April 6, 1999
Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cellsD S Allan, M Colonna, L L Lanier, et al.AIDS Research and Human Retroviruses|December 10, 1996
Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infectionP J Goulder, M Bunce, P Krausa, et al.European Journal of Immunology|December 1, 1995
Peptide anchor residue glycosylation: effect on class I major histocompatibility complex binding and cytotoxic T lymphocyte recognitionJ S Haurum, L Tan, G Arsequell, et al.Gene Therapy|May 28, 2004
Engineering RENTA, a DNA prime-MVA boost HIV vaccine tailored for Eastern and Central AfricaJ P Nkolola, E G-T Wee, E-J Im, et al.Journal of Neurology|April 12, 2007
Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, AustraliaI A F van der Mei, A-L Ponsonby, T Dwyer, et al.Immunogenetics|January 1, 1985
Characterization of the HLA-A2.2 subtype: T cell evidence for further heterogeneityF M Gotch, C Kelly, S A Ellis, et al.Pageof 33